↓ Skip to main content

The Glutathione Metabolite γ-Glutamyl-Glutamate Partially Activates Glutamate NMDA Receptors in Central Neurons With Higher Efficacy for GluN2B-Containing Receptors

Overview of attention for article published in Frontiers in Pharmacology, January 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Glutathione Metabolite γ-Glutamyl-Glutamate Partially Activates Glutamate NMDA Receptors in Central Neurons With Higher Efficacy for GluN2B-Containing Receptors
Published in
Frontiers in Pharmacology, January 2022
DOI 10.3389/fphar.2021.794680
Pubmed ID
Authors

Fatiha Sebih, Nawfel Mokrane, Pierre Fontanel, Mete Kayatekin, Mahira Kaabeche, Janique Guiramand, Catherine Cohen-Solal, Thierry Cens, Matthieu Rousset, Pierre Charnet, Marie-Céleste De Jésus Ferreira, Jean-Baptiste Thibaud, Claudine Ménard, Sonia Cantel, Valérie Rolland, Michel Vignes, Julien Roussel

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 29%
Student > Ph. D. Student 2 29%
Student > Master 1 14%
Unknown 2 29%
Readers by discipline Count As %
Neuroscience 2 29%
Biochemistry, Genetics and Molecular Biology 1 14%
Chemistry 1 14%
Agricultural and Biological Sciences 1 14%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2022.
All research outputs
#20,273,512
of 22,805,349 outputs
Outputs from Frontiers in Pharmacology
#10,039
of 16,018 outputs
Outputs of similar age
#408,888
of 498,931 outputs
Outputs of similar age from Frontiers in Pharmacology
#715
of 1,184 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,018 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 498,931 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,184 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.